We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Edgewise Therapeutics强调了在世界肌肉学会会议上展示的DUNE运动挑战和BMD纵向数据的发现。数据显示包括肌酸激酶 (CK)、肌红蛋白和TNNI2在内的生物标志物安慰剂反应较低，这表明存在真实的药物效果，支持显著的治疗差异。

Donovan, the Chief Medical Officer (CMO) of Edgewise Therapeutics, Inc. (NASDAQ:EWTX), sold shares of the company's common stock. The sale, which... John R. Moore, the General Counsel of Edgewise ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

NASDAQ EWTX opened at $34.00 on Friday. The stock has a market capitalization of $3.19 billion, a P/E ratio of -21.94 and a beta of 0.20. Edgewise Therapeutics, Inc. has a 1 year low of $5.12 and ...

Piper Sandler：维持Edgewise Therapeutics(EWTX.US)评级，由增持调整至增持评级, 目标价由48.00美元调整至51.00美元。 Edgewise Therapeutics（EWTX.US）公司简介 ...

Truist Financial analyst Srikripa Devarakonda assigned a Buy rating to the stock today. The company’s shares closed yesterday at $34.85.

In this article, we are going to take a look at where Edgewise Therapeutics, Inc. (NASDAQ:EWTX) stands against the other hot stocks. While the market is seeing significant positives after the Fed ...

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report)’s stock price shot up 4.5% on Friday after Piper Sandler raised their price target on the stock from $48.00 to $51.00. Piper Sandler ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...